Literature DB >> 2521357

Production of hematopoietic colony-stimulating factors by human natural killer cells.

M C Cuturi1, I Anegón, F Sherman, R Loudon, S C Clark, B Perussia, G Trinchieri.   

Abstract

We have analyzed the ability of highly purified preparations of human NK cells to produce CSF. NK cells, purified by negative selection from 10-d cultures of PBMC incubated with irradiated B-lymphoblastoid cell lines, were stimulated with rIL-2, FcR(CD16) ligands (particulate immune complexes or anti-CD16 antibodies bound to Sepharose), a combination of CD16 ligands and rIL-2, or the phorbol diester phorbol dibutyrate (PDBu) together with the Ca2+ ionophore A23187. Both rIL-2 and CD16 ligands induce accumulation of GM-CSF mRNA in NK cells and the combined effect of the two stimuli is synergistic. Maximal accumulation of GM-CSF mRNA is observed after PDBu/A23187 stimulation. The participation of contaminant T cells in the observed expression of the GM-CSF gene is excluded because CD16 ligands do not stimulate T cells and CD3 ligands, powerful stimulators of T cells, are inactive on NK cells. Accumulation of CSF-1 mRNA is observed only in NK cells stimulated with both CD16 ligands and rIL-2, whereas accumulation of IL-3 mRNA is observed only in NK cells stimulated with PDBu/A23187. Transcripts of the G-CSF, IL-1 alpha, and IL-1 beta genes were never detected in NK cells in these experiments. The kinetics of accumulation of GM-CSF and CSF-1 mRNA in NK cells stimulated with CD16 ligands and rIL-2 peaked at 2-4 h and was slower than that of TNF and IFN-gamma mRNA, which peak at 1 h. GM-CSF was precipitated from the supernatant fluids of NK cells stimulated with PDBu/A23187 and its biological activity was demonstrated by the ability of the supernatants to sustain proliferation of the TALL-101 cell line or CML blasts. Biological activity of IL-3 and CSF-1 was demonstrable in supernatant fluids of NK cells stimulated with PDBu/A23187 and CD16 ligands/rIL-2, respectively.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521357      PMCID: PMC2189209          DOI: 10.1084/jem.169.2.569

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  44 in total

1.  Isolation and DNA sequence of a full-length cDNA clone for human X chromosome-encoded phosphoglycerate kinase.

Authors:  A M Michelson; A F Markham; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

2.  Inhibition of in vitro granulopoiesis by autologous allogeneic human NK cells.

Authors:  M Hansson; M Beran; B Andersson; R Kiessling
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

3.  Terminal differentiation surface antigens of myelomonocytic cells are expressed in human promyelocytic leukemia cells (HL60) treated with chemical inducers.

Authors:  B Perussia; D Lebman; S H Ip; G Rovera; G Trinchieri
Journal:  Blood       Date:  1981-10       Impact factor: 22.113

4.  Characterization of an antigen expressed by human natural killer cells.

Authors:  J D Griffin; T Hercend; R Beveridge; S F Schlossman
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

5.  Induction of proliferation of purified human myeloid progenitor cells: a rapid assay for granulocyte colony-stimulating factors.

Authors:  J D Griffin; R Sullivan; R P Beveridge; P Larcom; S F Schlossman
Journal:  Blood       Date:  1984-04       Impact factor: 22.113

6.  Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor.

Authors:  T Kasahara; J Y Djeu; S F Dougherty; J J Oppenheim
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

7.  Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.

Authors:  D Santoli; Y C Yang; S C Clark; B L Kreider; D Caracciolo; G Rovera
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

8.  Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.

Authors:  B Perussia; S Starr; S Abraham; V Fanning; G Trinchieri
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

9.  Human neutrophil Fc gamma receptor distribution and structure.

Authors:  H B Fleit; S D Wright; J C Unkeless
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  42 in total

1.  Cardiomyopathy associated with high-dose interleukin-2 therapy.

Authors:  A C Beck; J H Ward; E H Hammond; R B Wray; W E Samlowski
Journal:  West J Med       Date:  1991-09

Review 2.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

3.  Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

Authors:  Cyril Fauriat; Eric O Long; Hans-Gustaf Ljunggren; Yenan T Bryceson
Journal:  Blood       Date:  2009-12-01       Impact factor: 22.113

4.  Cross-linking Fc receptors stimulate splenic non-B, non-T cells to secrete interleukin 4 and other lymphokines.

Authors:  S Z Ben-Sasson; G Le Gros; D H Conrad; F D Finkelman; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

5.  Natural killer activating receptors trigger interferon gamma secretion from T cells and natural killer cells.

Authors:  O Mandelboim; S Kent; D M Davis; S B Wilson; T Okazaki; R Jackson; D Hafler; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

6.  Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF.

Authors:  D K Blanchard; M B Michelini-Norris; C A Pearson; S McMillen; J Y Djeu
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

7.  IgE receptor-positive non-B/non-T cells dominate the production of interleukin 4 and interleukin 6 in immunized mice.

Authors:  I Aoki; C Kinzer; A Shirai; W E Paul; D M Klinman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 8.  Why clinicians should be interested in interleukin-3.

Authors:  P Valent; K Geissler; C Sillaber; K Lechner; P Bettelheim
Journal:  Blut       Date:  1990-12

9.  Altered coexpression of lectin-like receptors CD94 and CD161 on NK and T cells in HIV patients.

Authors:  Roland Jacobs; Klaus Weber; Katy Wendt; Hans Heiken; Reinhold E Schmidt
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

10.  Morphological, phenotypic and functional characteristics of a pure population of CD56+ CD16- CD3- large granular lymphocytes generated from human duodenal mucosa.

Authors:  G Pang; A Buret; R T Batey; Q Y Chen; L Couch; A Cripps; R Clancy
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.